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In brief
Background and aims
There is evidence from the US that contingency management can
be effective in reducing crack and cocaine use among opiate-
dependent patients receiving opiate substitution therapy. This
study tried to find out whether contingency management (or
variants of it) were being applied in England and what clinicians
thought about its potential. We also described the approach and
the experience of two services that were using contingency
management principles.
Design
The research involved a national survey of services providing
opiate substitution therapy and a qualitative study in two services
of staff using contingency management principles.
Findings
A range of positive reinforcement methods such as praise, use of
take-home privileges and eligibility for increased dose are used
routinely by most services. However, no services were identified
that used contingency management models conforming to the
evidence-based approaches described in the US literature. 
Many respondents were uncertain about the effectiveness of
contingency management in domestic drug treatment settings
and believed its use raised major ethical issues. 
Despite the concerns of a majority, there were a small number of
respondents who planned to introduce contingency management
into their practices. We looked at two such services in detail and
highlighted a number of problems concerning its implementation,
including finance, limited staff experience, anxieties about the
impact on client-keyworker relationships, the absence of practice
guidance and the need to undertake evaluation.
Main implications
The implementation of strict, protocol-driven contingency
management methods represents a significant change and
challenge to the current culture of English services providing
opiate substitution therapy. There needs to be a debate about the
ethical status of contingency management.
Services that are actively developing contingency management
should be supported in order to learn about practical problems
and to help researchers design a definitive trial. 
Disclaimer
This publication is not a journal publication and does not constitute National Treatment
Agency or Department of Health guidance or recommendations. The views expressed by
this study are not necessarily those of the Department of Health or the NTA, but are based
on externally refereed research.
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Introduction
This is a summary of the publication An Exploratory Study to
Assess the Feasibility of a Randomised Controlled Trial of
Contingency Management for the Treatment of Crack and
Cocaine Misuse in Opiate-Dependent Clients Receiving Opiate
Substitution Therapy (NTA, 2007).
Study aims
There are no evidence-based medical interventions for crack and
cocaine that are clinically effective or promote retention in
treatment. However, there is good evidence from US research
that contingency management can achieve significant reductions
in crack and cocaine use among opiate-dependent patients
receiving substitution therapy.
Despite this evidence base, there has been no research into the
feasibility or effectiveness of contingency management or
incentive-based treatment programmes in English drug treatment
settings. Moreover, the extent to which the principles of
contingency management have been implemented into drug
treatment in England is not known.
The aims of our study were:
• To measure the extent to which incentives are currently
employed in opiate substitution treatment in England
• To assess the attitude of clinicians towards contingency
management
• To investigate the issues and implications for practice raised
for clinics by current examples of incentive-based treatment
programmes.
Study methods
We addressed the study aims using a survey of English drug
treatment services that provided opiate substitution therapy. The
questionnaire was sent to the responsible medical practitioner at
each service. The survey was sent to 273 clinics of which 191
replied (70 per cent). 
We then observed the practice in two services, where
contingency management interventions using vouchers were
being developed or considered. Focus groups and qualitative
interviews were completed with clinicians in order to assess the
impact of incentive-based treatment programmes on clinic
regimes and ethical practice. They also aimed to identify any
clinical, organisational and ethical issues which would need to be
addressed in extending the practice of contingency management,
and of staging a trial of its effectiveness.
Findings
Opiate substitution services 
Extent of crack and cocaine misuse
The reported prevalence of regular crack misuse within the
current caseloads of clients receiving opiate substitution therapy
varied widely, but the median figure was 40 per cent. 
Contingency management is based upon principles of behaviour
modification. It involves providing positive reinforcement (in the
form of clinic privileges, vouchers or payment) when clients
achieve specified behaviours or treatment goals. There are four
key tenets which are common to all evidence-based models of
contingency management:
Defining a target behaviour 
The treatment team must clearly identify what outcome it wants
the client to achieve. Examples are abstinence from a specified
drug, compliance with clinic appointments and social activities
consistent with a drug-free lifestyle.
Regular monitoring of target behaviours
The treatment team must ensure that the behaviours being
targeted are regularly and unambiguously assessed – for
example, if the target behaviour is abstinence from a particular
drug, regular urine analysis would be undertaken.
Reward contingent on attainment of target behaviours
Rewards such as clinic privileges, payments, or vouchers or
tokens redeemable for goods and services consistent with a
drug-free life, are given to clients at pre-defined levels and
frequencies when target behaviours are demonstrated (for
example a negative urine test for cocaine). Rewards are withheld
when target behaviours are not achieved (for example a positive
urine test for cocaine). 
Reinforcement
In addition to rewards for clients achieving the target behaviour,
there should also be positive reinforcement through brief
counselling. 
What is contingency management?
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How do services respond to clients using crack and
cocaine?
Motivational interviewing, relapse prevention therapy and other
cognitive behaviour therapies are the first choice responses for
the majority of services when clients test positive for crack.
Negative reinforcement sanctions, such as reducing doses of
opiate substitutes are less commonly used. However, a quarter of
respondents said that clients at their clinics might at least be
warned about possible discharge, if they provided a number of
positive urine samples for cocaine. 
Types of positive reinforcement 
The survey revealed that a range of positive reinforcement
methods are used routinely by services. Virtually all clinics praised
clients who provided clean urine samples. Of the more tangible
forms of reinforcement, eligibility for take-home privileges and
eligibility for holiday treatment privileges were most commonly
reported. 
Just under a third of clinics told us that clients might be made
eligible for consideration for increased doses of opiate substitute,
while over a quarter said that providing urine samples negative for
cocaine would possibly make clients eligible to choose the type
of opiate substitute prescribed.
Less commonly reported forms of positive reinforcement
contingent on clean urine samples included progress from
supervised consumption to take-home privileges, fortnightly clinic
attendance instead of the standard weekly, prescribing anti-
depressants and eligibility for a detoxification programme.
Overall, eight out of ten services reported using at least two of the
positive reinforcement methods described above.
Similarities between UK and US services 
The study did not identify any opiate substitution therapy services
that were using models of contingency management that
conformed to the evidence-based approaches described in the
growing US literature. 
• No services were identified that offered either vouchers of
cash value or cash payments to clients contingent on the
provision of clean urine or the attainment of other behaviours
• Monitoring of urines for cocaine is relatively infrequent when
compared to that practised in the context of evidence-based
models of contingency management
• Significant proportions of respondents who reported that
positive reinforcement was employed in their clinical practices,
told us that rewards or privileges earned through abstinence
would not necessarily be withdrawn (even after repeated
positive tests). This suggests that the use of reinforcement
methods may currently exhibit ambiguity and offer scope for
negotiation, both of which would be inconsistent to the
principles of contingency management. 
Opinions among clinicians
Our findings reveal a high degree of uncertainty among clinicians
about the effectiveness of contingency management. A majority
of respondents felt the use of contingency management raises
major ethical issues. Nevertheless, around one in five
respondents felt contingency management was (or could be)
effective in their clinics and around a third felt that the ethical
issues raised were no more than ”minor” in nature.
Despite the concerns of a majority, there was a small number of
respondents who indicated they have plans to introduce
contingency management into their practices, and a larger
proportion indicated a desire to learn more about the practice
and effectiveness in English settings.
Findings from two incentivebased treatment programmes
Two services, referred to here as A and B, employed a range of
positive reinforcement methods and proposals for contingency
management interventions were being developed.
Types of positive reinforcement
Both services provided rewards contingent on the provision of
clean urine but the type, level and frequency of reward was
determined on a case-by-case basis. The following incentives
were employed: 
• Both services used praise as positive reinforcement. At
service A, some token-based reinforcement was employed
involving distribution of rewards such as travel tickets and
leisure passes 
• Supervision of consumption – daily supervised consumption
of methadone could be changed to three unsupervised pick-
ups a week 
• Take-home privileges – take-home treatment privileges were
used in both services as a reward for being stable or to
promote non-drug-related activities such as looking for a job
or visiting relations
• Increased prescription doses – under some circumstances
clients may receive increased doses of opiate substitute. Both
services had debated the use of diamorphine (medically
prescribed heroin) as a reward. 
While positive reinforcement was employed, this was not
practised on the basis of any formalised policies or protocols, and
took place largely in the context of one-to-one care co-ordination.
Reinforcement was individualised, responsive to client
circumstances and therefore negotiable within the context of the
client-keyworker relationship. There were suggestions that staff
perceived positive reinforcement as having greatest value in its
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potential to enhance the engagement of the clients with their
keyworkers, providing a more fertile basis for counselling-based
interventions. This is consistent with the finding of the survey that
a variety of rewards were more likely to be won by progress
towards treatment goals, than lost by non-compliance or relapse.
Proposals for extending contingency management
Service A was considering implementing a 12-week, voucher-
based scheme as a pilot project to encourage abstinence among
crack and cocaine users. Its target population was a small sub-
group of difficult-to-engage female sex workers. Urine testing
would be conducted three times a week. Each negative sample
would be rewarded with a voucher redeemable at shops such as
Boots. There would be incremental increases (from a starting rate
of £2.50) for every subsequent negative sample produced.
However, if a positive sample was provided then no voucher was
given and the value of the next voucher earned would return to
the starting rate.
Service B was also assessing the feasibility of a contingency
management intervention using vouchers. The intervention would
be targeted at clients using crack during the initial 3-6 month
phase of methadone maintenance treatment, when clients are
often chaotic and are required to attend for daily dispensing.
Some flexibility to tailor the treatment to individual need was
recognised in relation to the type of voucher, and also the
outcome being targeted. Monitoring of crack use was seen as a
problem because the clinic did not have the resources to routinely
test urine samples more than once a week. For this reason, other
measures of compliance had been considered such as
engagement with treatment, attendance at appointments,
attendance for collecting prescriptions or dispensing and
engaging with other services.
Issues
Services encountered several issues in using incentive-based
management and in planning for token-based contingency
management. There may be limited knowledge and experience
about the management of crack and cocaine use among staff
working in opiate substitution services. There was seen to be a
need for enhanced staff training in these areas.
At both of the services the implementation of contingency
management had been delayed by uncertainty over a number of
operational issues and a lack of evidence about best practice.
Staff were aware of evidence from the US but were uncertain
whether the models described in the literature were applicable to
England.
Key areas of uncertainty for staff included operational issues such
as the definition of target behaviours, eligibility criteria, intervention
duration and the level and type of reward to be offered. In relation
to each of these issues staff appear to be grappling (sometimes
with limited success) with an ever-present need to reconcile
clinical objectives, ethical considerations and the need for
evaluation.
Staff were very unclear about how clients might react to voucher-
based contingency management. There was concern that the
incentives would become the focus of treatment, rather than an
adjunct to existing interventions. Some felt clients might feel
manipulated by the scheme or patronised. There was also
concern that vouchers may undermine the client-keyworker
relationship, particularly when rewards might be lost or withheld.
Some staff were concerned that this might be demotivating to
some clients and might actually operate as reverse reinforcement.
This could be counterproductive to clients who generally do well,
albeit with occasional lapses.
The financing of contingency management also presented a
barrier to implementation. Once again, the discussions about
funding (particularly in relation to the rewards given to clients) took
place within the context of an ethical or (more problematically) a
moral debate. More prosaic, but nevertheless difficult, issues in
relation to finance concerned the necessary increase in the
frequency of urine analyses. As the survey revealed, few services
implement weekly urinalysis, let alone the thrice-weekly testing
employed by US services where effectiveness has been
demonstrated. 
Practice implications of the study
Strict, protocol-driven reinforcement methods that characterise
evidence-based models of contingency management might
represent a significant change and challenge to the current culture
of English services providing opiate substitution therapy. 
Contingency management is unlikely to be embraced by a
majority of professionals working in drug treatment without a
debate on its ethical status. There needs to a consensus
concerning the ethical case for conducting one or more domestic
trials.
In order to develop trials, those services that are actively
developing contingency management should be supported. This
should ensure that their practices are consistent with evidence-
based approaches and that information about the treatment
process, acceptability, impacts on the clinic regime and treatment
outcomes are obtained and used to inform the development of a
definitive trial. 
For contingency management to be successfully implemented at
a local level – with a level of fidelity that enables a valid
assessment of effectiveness to be undertaken – it will also likely
require;
• Careful logistical planning
• A strong commitment from service management
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• A commitment to make available additional resources to fund
the intervention and its evaluation. 
Study limitations
The survey achieved a good response rate and provided valuable
evidence about the extent and type of reinforcement methods
currently used. However, it focused on the views of medical
practitioners working in services providing opiate substitution
therapy and the findings should not be generalised to other
treatment settings and may not represent the views of other
professions working in drug treatment. 
Both of the services we studied were in the process of
developing contingency management and had not yet fully
implemented their proposals. Consequently, the findings from this
aspect of the study focused on issues concerned with design,
implementation and the management of certain clearly
anticipated problems. Data about the actual operation of
contingency management and the experience of participants
needs to obtained as these proposals are implemented, progress
and mature. 
To a large degree, the ambivalence workers expressed about the
value of contingency management reflected uncertainty about
how clients might respond to changes in clinic regime, and how
this might impact on the client-keyworker relationship. It is
therefore a significant limitation that we were unable to gauge the
views and experiences of service users. This must be a key focus
in future research.
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